Translational sciences in cardiac failure secondary to arteriovenous fistula in haemodialysis patients

Zahra, Syeda Anum, Choudhury, Rozina Yasmin, Basharat, Kamran, Tran, Tien, Begum, Munira, Abotabekh, Ahmed, Hedayat, Fatemah, Rimmer, Lara, Harky, Amer et al (2021) Translational sciences in cardiac failure secondary to arteriovenous fistula in haemodialysis patients. Annals of Vascular Surgery . ISSN 0890-5096

Full text not available from this repository.

Official URL: https://doi.org/10.1016/j.avsg.2021.01.071

Abstract

High-output cardiac failure is a rare form of heart failure associated with the formation of arteriovenous fistula (AVF) in haemodialysis patients. The pathophysiology underlying the HOCF is complex and multifactorial. Presence of AVF can cause long term haemodynamic changes that ultimately lead to increased cardiac output and consequently cardiac failure. A number of risk factors have been associated with the development of HOCF post-AVF construction, including male sex, a proximally located AVF and a state of volume overload. Dysregulation of tissue inhibitor of matrix metalloproteinase 4, Sirtuin-1 and Sirtuin-3 gene expression have been associated with the development of heart failure. The differences observed between genders have been attributed to altered activity of the β-adrenoceptor system. Numerous biomarkers including cardiac troponin T and I, atrial natriuretic peptide, brain natriuretic peptide amongst others have shown both prognostic and diagnostic potential; however further research is needed to establish their utility in clinical practice for patients with AVF associated HOCF. In recent years risk stratification models have been developed to help identify patients at the highest risk of developing HOCF post AVF which could be revolutionary in its identification and management. Potential options for managing HOCF post-AVF include AVF ligation, banding and anastoplasty however these procedures are not without their own associated risks. In this review, we discuss the pathophysiology, risk stratification and management of patients with AVF associated HOCF. [Abstract copyright: Copyright © 2021. Published by Elsevier Inc.]


Repository Staff Only: item control page